Information Note Agencia Española de Medicamentos y Productos Sanitarios AEMPS AMENDMENT OF INSTRUCTION ABOUT THE IMPLEMENTATION PROCEDURE OF THE EUROPEAN DECISION REGARDING VETERINARY MEDICINES ‘FORTEKOR’ AND ASSOCIATED NAMES Date of publication: 7th June 2012 Category: AEMPS, VETERINARY MEDICINES, INDUSTRY. Reference: MVET, 04_vi /2012 On the 20th February 2012 the AEMPS adopted the instruction 2/2012 regarding the procedure of implementation in Spain of the European Decision regarding veterinary medicines “FORTEKOR and associated names”. On the second point of the instruction, it was established that Marketing Authorisation Holders of the rest of veterinary medicines containing Benazepril hydrochloride, should submit the corresponding variation aimed to adapt their medicines to the conclusions of the Decision. Taking into account that this Decision was based on the legal basis of article 34 of the Directive 2001/82/CE of the European Parliament and of the Council which only applies to veterinary medicines FORTEKOR and associated names, but not to all of veterinary medicines containing Benazepril hydrochloride, through this instruction the AEMPS overrides the second point of instruction 2/2012. References AEMPS. [Web]. 24th February 2012. Information Note Instruction about the implementation procedure of the European Decision regarding veterinary medicines “FORTEKOR” and associated names. Ref. MVET, 01_vi/2012. Available on: http://www.aemps.gob.es/en/informa/notasInformativas/medicamentosVeterinarios/2012/NI -MVET_01-2012.htm (link revised on 7th June 2012). CORREO ELECTRÓNICO smuvaem@aemps.es Página 1 de 1 www.aemps.gob.es C/ CAMPEZO, 1 – EDIFICIO 8 28022 MADRID TEL: 91 822 54 01 FAX: 91 822 54 43 Fuente: AEMPS. Se autoriza la reproducción total o parcial del contenido de esta información, siempre que se cite expresamente su origen. La AEMPS pone a su disposición un servicio gratuito de suscripción a sus contenidos en la web: www.aemps.gob.es en la sección “listas de correo”.